Brian Richard Bear

This inventor holds 75 USPTO granted patents and 14 published patent applications, plus 18 CIPO patents and 33 EPO patents, primarily in Ion Channel Modulation (CPC class C07D). Top assignees: Vertex Pharmaceuticals, Inc., Bayer Healthcare LLC, Bayer Pharmaceuticals Corporation. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian Richard Bear. Retrieved from https://idiyas.com/inventor/brian-richard-bear

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 75 (Patent Applications = 14)

% Patents Active = 94.7

CIPO Patents = 18 (Patent Applications = 1)

EPO Patents = 33 (Patent Applications = 24)

Average Co-Inventor Count = 6.7

ph-index = 42

Forward Citations = 4,013(Granted Patents)

Forward Citations (Not Self Cited) = 2,866(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Oceanside, CA (US) (2009 - 2023)
Carlsbad, CA (US) (2014 - 2023)

Company Filing History:

73 out of 1,167

Vertex Pharmaceuticals, Inc.

Bayer Pharmaceuticals Corporation

patents

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

CFTR Modulators

Sodium Channels

ATP-Binding Cassette Transporters

Indole Derivatives

Pyridone Amides

Sulfonamides

Quinolines

Heteroaryl Derivatives

Chroman-Spirocyclic Piperidine

Azaindole Derivatives

Benzoxazines

Quinoxalines

75 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE50453 - Indole derivatives as CFTR modulators (2025-06-10),

2. 12168009 - Modulators of cystic fibrosis transmembrane conductance regulator (2024-12-17),

3. 11673864 - Pyridone amides as modulators of sodium channels (2023-06-13),

4. 11639347 - Modulators of ATP-binding cassette transporters (2023-05-02),

5. 11426407 - Modulators of cystic fibrosis transmembrane conductance regulator (2022-08-30),

6. 11203571 - Sulfonamides as modulators of sodium channels (2021-12-21),

7. 10987348 - Modulators of ATP-binding cassette transporters (2021-04-27),

8. 10975061 - Modulators of ATP-binding cassette transporters (2021-04-13),

9. 10758534 - Modulators of cystic fibrosis transmembrane conductance regulator (2020-09-01),

10. 10738030 - Modulators of cystic fibrosis transmembrane conductance regulator (2020-08-11),

11. 10738009 - Pyridone amides as modulators of sodium channels (2020-08-11),

12. 10385070 - Chroman-spirocyclic piperidine amides as modulators of ion channels (2019-08-20),

13. 10258624 - Modulators of cystic fibrosis transmembrane conductance regulator (2019-04-16),

14. 10239867 - Modulators of ATP-binding cassette transporters (2019-03-26),

15. 10087143 - Pyridone amides as modulators of sodium channels (2018-10-02),

Title: Inspiring the Future: The Innovations of Inventor Brian Richard Bear

Introduction:

Inventor Brian Richard Bear, based in Carlsbad, CA (US), continues to blaze a trail of visionary ideas and relentless pursuit of excellence, inspiring the next generation of inventors. With an impressive portfolio of 73 patents, his impact on the world of innovation is undeniably remarkable, promising a lasting legacy for years to come.

Latest Patents:

Among his latest patents is the groundbreaking invention of Pyridone amides as modulators of sodium channels. These compounds are vital inhibitors of sodium channels, with vast potential in treating various disorders, notably pain. Additionally, his work on Modulators of ATP-binding cassette transporters showcases his versatility in developing treatments for ABC transporter mediated diseases, such as Cystic Fibrosis.

Career Highlights:

Brian Richard Bear has made significant contributions to innovation during his tenure at renowned companies like Vertex Pharmaceuticals, Inc. and Bayer Healthcare LLC. His expertise in the pharmaceutical and biotechnology sectors has led to groundbreaking discoveries that have shaped the industry.

Collaborations:

Throughout his career, Brian Richard Bear has collaborated closely with accomplished individuals in the field of innovation. Notable coworkers include Mark Thomas Miller and Jinglan Zhou, who have played pivotal roles in bringing his visionary ideas to fruition.

Conclusion:

Inventor Brian Richard Bear's unwavering dedication to pushing the boundaries of innovation underscores his status as a true trailblazer in the field. His pioneering work in developing cutting-edge pharmaceutical compounds and treatments continues to leave a lasting impact on the industry, inspiring generations of inventors to come.

Profile summary based on public USPTO records.